GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37029
Submission : 2022-05-04
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19653
Submission : 2006-07-04
Status : Active
Type : IV
Date of Issue : 2024-03-21
Valid Till : 2026-02-08
Written Confirmation Number : WC-0479
Address of the Firm :
Date of Issue : 2024-03-21
Valid Till : 2026-02-08
Written Confirmation Number : WC-0479
Address of the Firm :
Date of Issue : 2024-03-21
Valid Till : 2026-02-08
Written Confirmation Number : WC-0479
Address of the Firm :
Date of Issue : 2024-03-21
Valid Till : 2026-08-02
Written Confirmation Number : WC-479
Address of the Firm :
Date of Issue : 2024-03-21
Valid Till : 2026-08-02
Written Confirmation Number : WC-479
Address of the Firm :
Date of Issue : 2024-03-21
Valid Till : 2026-08-02
Written Confirmation Number : WC-479
Address of the Firm :
Date of Issue : 2024-03-21
Valid Till : 2026-08-02
Written Confirmation Number : WC-479
Address of the Firm :
Date of Issue : 2024-03-21
Valid Till : 2026-08-02
Written Confirmation Number : WC-479
Address of the Firm :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19653
Submission : 2006-07-04
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37029
Submission : 2022-05-04
Status : Active
Type : IV
FINISHED DOSAGE FORMULATIONS
ISONIAZID; PYRAZINAMIDE; RIFAMPIN
Drug : RIFATER
Dosage Form : TABLET; ORAL
Application Number : 50705
Country : US
Patented : No
Drug : FLOMAX
Dosage Form : CAPSULE; ORAL
Application Number : 20579
Country : US
Patented : No
Drug : TRICOR
Dosage Form : TABLET; ORAL
Application Number : 21656
Country : US
Patented : No
Drug : PROGESTERONE
Dosage Form : CAPSULE; ORAL
Application Number : 208801
Country : US
Patented : No
Drug : SEVELAMER CARBONATE
Dosage Form : TABLET; ORAL
Application Number : 206094
Country : US
Patented : No
Drug : OXCARBAZEPINE
Dosage Form : TABLET; ORAL
Application Number : 78069
Country : US
Patented : No
Drug : AMOXICILLIN
Dosage Form : CAPSULE; ORAL
Application Number : 62881
Country : US
Patented : No
Drug : MYCOPHENOLATE MOFETIL
Dosage Form : FOR SUSPENSION; ORAL
Application Number : 212634
Country : US
Patented : No
Drug : DUTASTERIDE
Dosage Form : CAPSULE; ORAL
Application Number : 208227
Country : US
Patented : No
Drug : IBUPROFEN
Dosage Form : TABLET; ORAL
Application Number : 79129
Country : US
Patented : No
EXCIPIENTS BY APPLICATIONS
MARKET PLACE
Reply
19 Sep 2022
Reply
17 Oct 2019